FDA.reportPublic FDA data

PALIPERIDONE

Substance profile for UNII 838F01T721, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for PALIPERIDONE
Structure render from PubChem CID 115237

Substance Identity#

UNII
838F01T721
Preferred term
PALIPERIDONE
Registry number
144598-75-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C23H27FN4O3
Chemical structure for PALIPERIDONE
Structure render from PubChem CID 115237

Chemical And Database Identifiers#

SMILES
CC1=C(CCN2CCC(CC2)C3=NOC4=C3C=CC(F)=C4)C(=O)N5CCCC(O)C5=N1
RxCUI
679314
PubChem
115237
NCIt
C66293
INN ID
7977

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound115237pubchem.ncbi.nlm.nih.gov/compound/115237
RxNorm679314mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=679314
NCI ThesaurusC66293ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66293
FDA Substance Registration System838F01T721precision.fda.gov/uniisearch/srs/unii/838F01T721

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use INVEGA safely and effectively. See full prescribing information for INVEGA . INVEGA (paliperidone) Extended-Release Tablets Initial U.S. Approval: 2006 ® ® ®2
ACTIVE INGREDIENTThese highlights do not include all the information needed to use INVEGA safely and effectively. See full prescribing information for INVEGA . INVEGA (paliperidone) Extended-Release Tablets Initial U.S. Approval: 2006 ® ® ®2
ACTIVE INGREDIENTThese highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 20061
ACTIVE MOIETYThese highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 20061
ACTIVE MOIETYINVEGA SUSTENNA (PALIPERIDONE PALMITATE) INJECTION [JANSSEN PHARMACEUTICALS, INC.]19
ACTIVE MOIETYPALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]18
ACTIVE INGREDIENTPALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]18
ACTIVE INGREDIENTINVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.]17
ACTIVE MOIETYINVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.]17
ACTIVE INGREDIENTPALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]2
ACTIVE MOIETYPALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]2
ACTIVE INGREDIENTINVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
ACTIVE MOIETYINVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
ACTIVE MOIETYINVEGA TRINZA (PALIPERIDONE PALMITATE) INJECTION, SUSPENSION, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC]1
ACTIVE INGREDIENTPALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
ACTIVE MOIETYPALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
ACTIVE MOIETYPALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
ACTIVE INGREDIENTPALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
ACTIVE MOIETYPALIPERIDONE TABLET, EXTENDED RELEASE [PATRIOT PHARMACEUTICALS, LLC]1
ACTIVE INGREDIENTPALIPERIDONE TABLET, EXTENDED RELEASE [PATRIOT PHARMACEUTICALS, LLC]1